NEW YORK (GenomeWeb) – Meridian Bioscience announced this week that the US Food and Drug Administration has cleared new claims for the firm's illumigene Pertussis molecular amplification test. The new claims include specimens collected by Copan Diagnostics' ESwab multitransport universal transport system. The FDA cleared the illumigene Pertussis test in March 2014.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The apple has traveled westward and eastward along the Silk Road, according to a new genetic analysis.

In Nature this week: GWAS data used to reposition drugs for psychiatric use, and more.

Genetic disease risk information doesn't always spur people to make healthy lifestyle changes, according to the Associated Press.

A University of California, San Diego-led team has used liquid biopsies to uncover possible treatments for patients with cancers of unknown primary.